Clinical application of autoimmune neurological diseases related antibodies / 中华检验医学杂志
Xiangjun CHEN.
Chinese Journal of Laboratory Medicine
; (12): 573-576, 2014.
Artículo
en Zh
| WPRIM | ID: wpr-454495
Autoimmune neurological diseases have a high morbidity and mortality,but are treatable if diagnosed earlier.Many auto-antibodies may become important laboratory biomarkers for the diagnosis,evaluating severity,prognosis,and even reflecting treatment response,of these diseases.With the development of new knowledge and diagnostic technology,there is a pending need for discovering new pathogenesis-based biomarkers with high sensitivity and specificity on autoimmune diseases of the nervous system.To fulfill this goal,the pathogenesis as well as translational studies in autoimmune diseases of the nervous system are highly warranted.Multi-center randomized double-blinded clinical trials are also necessary to appropriately evaluate the clinical value of these auto-antibodies.W henever possible,these validated autoantibody assays are readily encouraged to perform and popularize these methods in clinical practice.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados